Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;8(2):88-92.
doi: 10.3724/SP.J.1263.2011.00088.

Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population

Dao-Kuo Yao  1 , Le-Xin Wang, Shane Curran, Patrick Ball
Affiliations

Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population

Dao-Kuo Yao et al. J Geriatr Cardiol. 2011 Jun.

Abstract

Background: To document the pharmacotherapy of chronic heart failure (CHF) and to evaluate the adherence to treatment guidelines in Australian population.

Methods: The pharmacological management of 677 patients (female 46.7%, 75.5 ± 11.6 years) with CHF was retrospectively analyzed.

Results: The use of angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARB) and β-blockers were 58.2 % and 34.7 %, respectively. Major reasons for non-use of ACE inhibitors/ARBs were hyperkalemia and elevated serum creatinine level. For patients who did not receive β-blockers, asthma and chronic obstructive pulmonary disease were the main contraindications. Treatment at or above target dosages for ACE inhibitors/ARBs and β-blockers was low for each medication (40.3% and 28.9%, respectively).

Conclusions: Evidenced-based medical therapies for heart failure were under used in a rural patient population. Further studies are required to develop processes to improve the optimal use of heart failure medications.

Keywords: ACE inhibitors; angiotensin receptor; heart failure; prognosis; β-blockers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. McLean AS, Eslick GD, Coats AJ. The epidemiology of heart failure in Australia. Int J Cardiol. 2007;118(3):370–374. - PubMed
    1. Krum H, Tonkin AM, Currie R, et al. Chronic heart failure in Australian general practice: the Cardiac Awareness Survey and Evaluation (CASE) study. Med J Aust. 2001;174(9):439–444. - PubMed
    1. He SW, Wang LX. Impact of anaemia on the outcomes of chronic heart failure: a meta-analysis and systemic review. Congest Heart Fail. 2009;15(3):123–130. - PubMed
    1. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: Survival trends in 12,220 index admissions in Leicestershire 1993–2001. Heart. 2003;89(6):615–620. - PMC - PubMed
    1. Krum H, Jelinek MV, Stewart S, et al. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust. 2006;185(10):549–556. - PubMed

LinkOut - more resources